EUVIMEDEUVIMED entdecken
Netzwerk-MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Efficacy and Safety of Perioperative Immunotherapy for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis

Zhijuan Du, Siyuan Chen iD, Yuhui Qin, Yahui Lv, Xiangyu Du, Heying Yu, Zhefeng Liu

Current Oncology · 2025

DOI: 10.3390/curroncol32030184 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Current Oncology, 2025. Verfasst von Zhijuan Du und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Chinese PLA, Beijing 100853, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Immunotherapy, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this study is to indirectly compare the efficacy and safety of all currently available neoadjuvant chemoimmunotherapy and perioperative chemoimmunotherapy in randomized controlled trials (RCTs) involving patients with resectable non-small cell lung cancer (NSCLC) to identify optimal treatment regimens.

Methods

Eligible studies evaluating neoadjuvant chemoimmunotherapy and perioperative chemoimmunotherapy-based regimens in resectable NSCLC patients were included. Clinical outcomes were extracted for event-free survival (EFS) and overall survival (OS), as well as the incidence of pathological complete response (pCR), major pathological response (MPR), any-grade adverse events (AEs), and treatment-related adverse events (TRAEs) in the Bayesian framework. A subgroup analysis of EFS was conducted according to PD-L1 expression, histological type and reaching pCR or not.

Results

We selected eight RCTs involving 3113 patients. Our analysis found no significant differences between perioperative immunotherapy and neoadjuvant immunotherapy in terms of MPR (RR 0.72, 95% CI 0.39 –1.3), pCR (RR 0.73, 95% CI 0.24–2.3), EFS (HR 0.95, 95% CI 0.56–1.7), and OS (HR 95% CI 3.9–4.2). Subgroup analyses revealed that neoadjuvant immunotherapy demonstrated superiority in the programmed death-ligand 1 (PD-L1) high-expression cohort, the non-squamous cell carcinoma cohort, and the non-smoking cohort. Conversely, perioperative immunotherapy ranked first in the PD-L1 low-expression cohort, squamous cell carcinoma cohort, and non-pCR cohort.

Conclusions

Our findings indicate that neoadjuvant immunotherapy and perioperative immunotherapy exhibit comparable efficacy in patients with NSCLC. These results provide valuable evidence for guiding the treatment of patients with resectable NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungImmunotherapyLung NeoplasmsHumansNeoadjuvant TherapyPerioperative CareRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Bayesian network meta-analysisimmune checkpoint inhibitornon-small cell lung cancerperioperative immunotherapy

Autor:innen und Institutionen

  • Medical School of Chinese PLA, Beijing 100853, China.
  • Department of Medical Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
  • Department of Medical Oncology, The Third Medical Center of Chinese PLA General Hospital, Beijing 100089, China.
  • Department of Medical Oncology, Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.

ORCID-Profile: Siyuan Chen

Zitieren

APA

Du, Z., Chen, S., Qin, Y., Lv, Y., Du, X., Yu, H., & Liu, Z. (2025). Efficacy and Safety of Perioperative Immunotherapy for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis. Current Oncology. https://doi.org/10.3390/curroncol32030184

Vancouver

Du Z, Chen S, Qin Y, Lv Y, Du X, Yu H, et al. Efficacy and Safety of Perioperative Immunotherapy for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis. Current Oncology. 2025. doi:10.3390/curroncol32030184

BibTeX
@article{Du2025,
  author = {Du, Zhijuan and Chen, Siyuan and Qin, Yuhui and Lv, Yahui and Du, Xiangyu and Yu, Heying and Liu, Zhefeng},
  title = {Efficacy and Safety of Perioperative Immunotherapy for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32030184}
}
Kostenlos starten →